Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 22 | 2018 | 610 | 4.850 |
Why?
|
| Survivors | 20 | 2016 | 145 | 4.640 |
Why?
|
| Smoking | 11 | 2017 | 427 | 2.610 |
Why?
|
| Head and Neck Neoplasms | 5 | 2018 | 117 | 2.090 |
Why?
|
| Smoking Cessation | 6 | 2017 | 118 | 1.810 |
Why?
|
| Rural Population | 8 | 2020 | 246 | 1.780 |
Why?
|
| Breast Neoplasms | 9 | 2020 | 666 | 1.750 |
Why?
|
| Healthcare Disparities | 8 | 2018 | 153 | 1.620 |
Why?
|
| Lung Neoplasms | 7 | 2019 | 384 | 1.600 |
Why?
|
| Medical Oncology | 4 | 2019 | 70 | 1.400 |
Why?
|
| Health Services Needs and Demand | 5 | 2020 | 66 | 1.340 |
Why?
|
| National Cancer Institute (U.S.) | 2 | 2019 | 14 | 1.320 |
Why?
|
| Colorectal Neoplasms | 5 | 2020 | 208 | 1.250 |
Why?
|
| Women's Health | 3 | 2017 | 226 | 1.230 |
Why?
|
| Middle Aged | 43 | 2020 | 10829 | 1.190 |
Why?
|
| Aged | 35 | 2020 | 9487 | 1.150 |
Why?
|
| Quality of Life | 10 | 2020 | 816 | 1.120 |
Why?
|
| Female | 50 | 2020 | 18164 | 1.090 |
Why?
|
| Aged, 80 and over | 18 | 2020 | 3717 | 1.070 |
Why?
|
| Humans | 59 | 2020 | 29093 | 1.040 |
Why?
|
| Health Behavior | 3 | 2017 | 214 | 1.000 |
Why?
|
| Caregivers | 3 | 2018 | 94 | 1.000 |
Why?
|
| Urban Population | 6 | 2019 | 79 | 1.000 |
Why?
|
| Adaptation, Psychological | 7 | 2018 | 125 | 0.990 |
Why?
|
| Delivery of Health Care | 3 | 2017 | 142 | 0.990 |
Why?
|
| Health Status Disparities | 4 | 2015 | 113 | 0.980 |
Why?
|
| Cross-Sectional Studies | 12 | 2020 | 1356 | 0.970 |
Why?
|
| Mental Health | 2 | 2016 | 104 | 0.940 |
Why?
|
| Male | 40 | 2020 | 17807 | 0.930 |
Why?
|
| Health Promotion | 3 | 2016 | 220 | 0.920 |
Why?
|
| United States | 17 | 2019 | 3630 | 0.910 |
Why?
|
| Stress, Psychological | 6 | 2018 | 208 | 0.870 |
Why?
|
| Adult | 29 | 2020 | 8420 | 0.850 |
Why?
|
| Health Services Accessibility | 5 | 2013 | 231 | 0.850 |
Why?
|
| Needs Assessment | 2 | 2020 | 66 | 0.840 |
Why?
|
| Prostatic Neoplasms | 3 | 2020 | 441 | 0.840 |
Why?
|
| Quality of Health Care | 3 | 2020 | 134 | 0.800 |
Why?
|
| Attitude to Health | 2 | 2017 | 148 | 0.770 |
Why?
|
| Primary Health Care | 3 | 2018 | 178 | 0.680 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 298 | 0.640 |
Why?
|
| Patient Education as Topic | 1 | 2020 | 251 | 0.630 |
Why?
|
| Models, Theoretical | 3 | 2009 | 126 | 0.620 |
Why?
|
| Radiology | 1 | 2017 | 37 | 0.600 |
Why?
|
| Health Services Research | 1 | 2017 | 78 | 0.600 |
Why?
|
| Early Detection of Cancer | 4 | 2019 | 73 | 0.600 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2006 | 28 | 0.580 |
Why?
|
| Biomedical Research | 1 | 2017 | 153 | 0.550 |
Why?
|
| Rest | 1 | 2015 | 49 | 0.540 |
Why?
|
| Self Disclosure | 1 | 2015 | 23 | 0.530 |
Why?
|
| Neural Pathways | 1 | 2015 | 97 | 0.530 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 169 | 0.530 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2015 | 9 | 0.520 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 142 | 0.520 |
Why?
|
| Brain Mapping | 1 | 2015 | 182 | 0.520 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 113 | 0.510 |
Why?
|
| Disability Evaluation | 1 | 2016 | 211 | 0.510 |
Why?
|
| Health Expenditures | 3 | 2015 | 61 | 0.510 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 162 | 0.500 |
Why?
|
| Patients | 2 | 2012 | 46 | 0.490 |
Why?
|
| Patient Participation | 1 | 2014 | 62 | 0.490 |
Why?
|
| Treatment Refusal | 1 | 2013 | 10 | 0.480 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 150 | 0.480 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 355 | 0.470 |
Why?
|
| Health Status | 6 | 2018 | 368 | 0.470 |
Why?
|
| Communication | 1 | 2014 | 122 | 0.470 |
Why?
|
| Mental Disorders | 1 | 2014 | 103 | 0.460 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 29 | 0.450 |
Why?
|
| Tamoxifen | 1 | 2013 | 48 | 0.450 |
Why?
|
| Counseling | 4 | 2014 | 85 | 0.440 |
Why?
|
| Ethnic Groups | 3 | 2018 | 440 | 0.430 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 337 | 0.430 |
Why?
|
| Health Personnel | 2 | 2018 | 111 | 0.420 |
Why?
|
| Continental Population Groups | 1 | 2013 | 221 | 0.410 |
Why?
|
| HIV Seropositivity | 3 | 2006 | 13 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 326 | 0.400 |
Why?
|
| Medication Adherence | 1 | 2013 | 144 | 0.400 |
Why?
|
| Tobacco Use Disorder | 2 | 2010 | 76 | 0.400 |
Why?
|
| Mass Screening | 3 | 2019 | 223 | 0.390 |
Why?
|
| Child of Impaired Parents | 1 | 2010 | 3 | 0.390 |
Why?
|
| Adolescent | 9 | 2015 | 3254 | 0.380 |
Why?
|
| Postoperative Complications | 1 | 2015 | 670 | 0.370 |
Why?
|
| Self Efficacy | 2 | 2014 | 70 | 0.360 |
Why?
|
| Age Factors | 4 | 2019 | 1108 | 0.350 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 25 | 0.340 |
Why?
|
| Viral Load | 2 | 2006 | 64 | 0.330 |
Why?
|
| Brain | 1 | 2015 | 930 | 0.330 |
Why?
|
| Maternal Behavior | 1 | 2008 | 3 | 0.330 |
Why?
|
| Treatment Outcome | 8 | 2017 | 3099 | 0.310 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 80 | 0.310 |
Why?
|
| Patient Compliance | 2 | 2006 | 208 | 0.300 |
Why?
|
| Risk Factors | 6 | 2015 | 3531 | 0.290 |
Why?
|
| European Continental Ancestry Group | 4 | 2015 | 1131 | 0.270 |
Why?
|
| Socioeconomic Factors | 6 | 2014 | 391 | 0.270 |
Why?
|
| Patient-Centered Care | 2 | 2018 | 68 | 0.270 |
Why?
|
| Patient Satisfaction | 4 | 2018 | 222 | 0.270 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1013 | 0.270 |
Why?
|
| Anorexia Nervosa | 1 | 2005 | 3 | 0.260 |
Why?
|
| Cotinine | 2 | 2015 | 45 | 0.260 |
Why?
|
| Logistic Models | 4 | 2014 | 727 | 0.260 |
Why?
|
| Health Surveys | 2 | 2016 | 191 | 0.240 |
Why?
|
| Self Care | 1 | 2005 | 137 | 0.240 |
Why?
|
| Specialization | 2 | 2014 | 30 | 0.230 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 2108 | 0.200 |
Why?
|
| Social Support | 3 | 2014 | 163 | 0.200 |
Why?
|
| Comorbidity | 3 | 2014 | 540 | 0.200 |
Why?
|
| Data Collection | 2 | 2018 | 163 | 0.190 |
Why?
|
| Appalachian Region | 1 | 2020 | 16 | 0.190 |
Why?
|
| Decision Making | 2 | 2014 | 180 | 0.180 |
Why?
|
| HIV Infections | 1 | 2004 | 335 | 0.180 |
Why?
|
| Young Adult | 3 | 2015 | 2402 | 0.170 |
Why?
|
| California | 3 | 2014 | 60 | 0.170 |
Why?
|
| Prevalence | 3 | 2017 | 896 | 0.170 |
Why?
|
| African Americans | 3 | 2015 | 1373 | 0.170 |
Why?
|
| Physicians | 2 | 2012 | 134 | 0.170 |
Why?
|
| Hispanic Americans | 3 | 2014 | 904 | 0.160 |
Why?
|
| Research Support as Topic | 1 | 2017 | 25 | 0.160 |
Why?
|
| Hostility | 1 | 2017 | 3 | 0.160 |
Why?
|
| Medically Underserved Area | 1 | 2017 | 22 | 0.160 |
Why?
|
| Obesity | 3 | 2014 | 1063 | 0.150 |
Why?
|
| Cardiac Volume | 1 | 2017 | 11 | 0.150 |
Why?
|
| Minority Groups | 1 | 2017 | 69 | 0.150 |
Why?
|
| Prognosis | 3 | 2017 | 1362 | 0.150 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 73 | 0.150 |
Why?
|
| Florida | 2 | 2008 | 33 | 0.150 |
Why?
|
| Health Care Surveys | 2 | 2018 | 176 | 0.150 |
Why?
|
| Heart Ventricles | 1 | 2017 | 107 | 0.140 |
Why?
|
| Demography | 1 | 2016 | 104 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 136 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2015 | 21 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 194 | 0.130 |
Why?
|
| Postmenopause | 1 | 2017 | 397 | 0.130 |
Why?
|
| Odds Ratio | 2 | 2013 | 447 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2017 | 2019 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2016 | 436 | 0.130 |
Why?
|
| Shame | 1 | 2014 | 2 | 0.130 |
Why?
|
| Radiation Dosage | 1 | 2015 | 72 | 0.130 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 546 | 0.130 |
Why?
|
| Long-Term Care | 1 | 2014 | 21 | 0.130 |
Why?
|
| Resilience, Psychological | 1 | 2014 | 15 | 0.130 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 110 | 0.130 |
Why?
|
| Stroke Volume | 1 | 2017 | 278 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 301 | 0.120 |
Why?
|
| Life Style | 2 | 2013 | 364 | 0.120 |
Why?
|
| Hot Flashes | 1 | 2014 | 46 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 871 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 242 | 0.120 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2014 | 20 | 0.120 |
Why?
|
| Yoga | 1 | 2014 | 41 | 0.120 |
Why?
|
| Length of Stay | 1 | 2015 | 292 | 0.120 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2013 | 9 | 0.120 |
Why?
|
| Radiography | 1 | 2015 | 353 | 0.120 |
Why?
|
| Health Services | 1 | 2014 | 35 | 0.120 |
Why?
|
| Quinazolines | 1 | 2013 | 31 | 0.120 |
Why?
|
| Withholding Treatment | 1 | 2013 | 11 | 0.120 |
Why?
|
| Menopause | 1 | 2014 | 86 | 0.120 |
Why?
|
| National Health Programs | 1 | 2013 | 4 | 0.120 |
Why?
|
| Refusal to Participate | 1 | 2013 | 4 | 0.120 |
Why?
|
| Patient Preference | 1 | 2013 | 38 | 0.110 |
Why?
|
| Genital Neoplasms, Female | 1 | 2013 | 15 | 0.110 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 25 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 726 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 53 | 0.110 |
Why?
|
| Aftercare | 1 | 2013 | 28 | 0.110 |
Why?
|
| Time Factors | 3 | 2017 | 2001 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2014 | 181 | 0.110 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 93 | 0.110 |
Why?
|
| Medicaid | 1 | 2013 | 83 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2013 | 274 | 0.110 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 163 | 0.110 |
Why?
|
| Hormone Replacement Therapy | 1 | 2013 | 86 | 0.110 |
Why?
|
| Poverty | 1 | 2013 | 99 | 0.110 |
Why?
|
| Exercise | 2 | 2018 | 591 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2013 | 78 | 0.110 |
Why?
|
| Outpatients | 1 | 2012 | 49 | 0.100 |
Why?
|
| Psychology | 2 | 2008 | 22 | 0.100 |
Why?
|
| Patient Selection | 1 | 2013 | 257 | 0.100 |
Why?
|
| Brain Neoplasms | 1 | 2017 | 587 | 0.100 |
Why?
|
| Population Groups | 1 | 2010 | 7 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1218 | 0.090 |
Why?
|
| Leukemia | 1 | 2009 | 36 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 366 | 0.090 |
Why?
|
| Aging | 1 | 2016 | 881 | 0.090 |
Why?
|
| Depression | 2 | 2018 | 380 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2014 | 469 | 0.090 |
Why?
|
| African Continental Ancestry Group | 1 | 2010 | 350 | 0.090 |
Why?
|
| Social Class | 1 | 2009 | 78 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2013 | 1687 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 13 | 0.080 |
Why?
|
| Causality | 1 | 2008 | 37 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2010 | 598 | 0.080 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2008 | 88 | 0.080 |
Why?
|
| Infant | 1 | 2010 | 969 | 0.080 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2009 | 179 | 0.070 |
Why?
|
| Social Adjustment | 1 | 2006 | 8 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2010 | 1167 | 0.070 |
Why?
|
| Attitude | 1 | 2006 | 37 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 199 | 0.070 |
Why?
|
| HIV-1 | 1 | 2006 | 42 | 0.070 |
Why?
|
| SEER Program | 2 | 2018 | 32 | 0.070 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 43 | 0.070 |
Why?
|
| Hypertension | 1 | 2013 | 906 | 0.070 |
Why?
|
| Feminism | 1 | 2005 | 1 | 0.070 |
Why?
|
| Obsessive Behavior | 1 | 2005 | 3 | 0.070 |
Why?
|
| Psychological Theory | 1 | 2005 | 6 | 0.070 |
Why?
|
| Psychology, Social | 1 | 2005 | 2 | 0.070 |
Why?
|
| Pregnancy | 1 | 2008 | 815 | 0.070 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 281 | 0.060 |
Why?
|
| Homosexuality, Male | 1 | 2005 | 73 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2005 | 89 | 0.060 |
Why?
|
| Models, Biological | 1 | 2006 | 373 | 0.060 |
Why?
|
| Child | 1 | 2010 | 2219 | 0.060 |
Why?
|
| Spirituality | 1 | 2004 | 33 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 720 | 0.060 |
Why?
|
| Registries | 2 | 2014 | 278 | 0.050 |
Why?
|
| Cognition | 1 | 2004 | 526 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 637 | 0.040 |
Why?
|
| Gender Identity | 1 | 2018 | 18 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2018 | 97 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 63 | 0.040 |
Why?
|
| Diastole | 1 | 2017 | 90 | 0.040 |
Why?
|
| Medicare | 1 | 2018 | 186 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 64 | 0.040 |
Why?
|
| Anxiety | 1 | 2018 | 159 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2017 | 440 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 374 | 0.030 |
Why?
|
| Narration | 1 | 2014 | 10 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 48 | 0.030 |
Why?
|
| Self Concept | 1 | 2014 | 41 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 74 | 0.030 |
Why?
|
| Los Angeles | 1 | 2014 | 8 | 0.030 |
Why?
|
| Filgrastim | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cyclin D3 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Survival | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 21 | 0.030 |
Why?
|
| Missouri | 1 | 2013 | 12 | 0.030 |
Why?
|
| Radiosurgery | 1 | 2017 | 322 | 0.030 |
Why?
|
| North Carolina | 1 | 2018 | 1423 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 65 | 0.030 |
Why?
|
| Taxoids | 1 | 2013 | 47 | 0.030 |
Why?
|
| Cisplatin | 1 | 2013 | 69 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 77 | 0.030 |
Why?
|
| Research Subjects | 1 | 2013 | 28 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 248 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 246 | 0.030 |
Why?
|
| Overweight | 1 | 2014 | 256 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 865 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 863 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2010 | 80 | 0.020 |
Why?
|
| Tobacco | 1 | 2010 | 50 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2013 | 401 | 0.020 |
Why?
|
| Chicago | 1 | 2009 | 8 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2017 | 3111 | 0.020 |
Why?
|
| Psychometrics | 1 | 2009 | 129 | 0.020 |
Why?
|
| Illinois | 1 | 2007 | 9 | 0.020 |
Why?
|
| Electronics | 1 | 2006 | 14 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2006 | 16 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2006 | 24 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2006 | 91 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2006 | 249 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 462 | 0.020 |
Why?
|
| Incidence | 1 | 2006 | 1119 | 0.010 |
Why?
|